Lycium barbarum polysaccharides (LBPs) supplementation was reported to reduce CCl4-induced oxidative injury, inflammatory response, and TLRs/NF-kB signaling pathway expression, which alleviated CCl4-induced liver fibrosis (132). The gene discussed is NFKB1; the disease is Hepatic fibrosis.